Blood Pressure Management for Ischemic Stroke in the First 24 Hours

Επιστημονική δημοσίευση - Άρθρο Περιοδικού uoadl:3220244 54 Αναγνώσεις

Μονάδα:
Ερευνητικό υλικό ΕΚΠΑ
Τίτλος:
Blood Pressure Management for Ischemic Stroke in the First 24 Hours
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
High blood pressure (BP) is common after ischemic stroke and associated with a poor functional outcome and increased mortality. The conundrum then arises on whether to lower BP to improve outcome or whether this will worsen cerebral perfusion due to aberrant cerebral autoregulation. A number of large trials of BP lowering have failed to change outcome whether treatment was started prehospital in the community or hospital. Hence, nuances on how to manage high BP are likely, including whether different interventions are needed for different causes, the type and timing of the drug, how quickly BP is lowered, and the collateral effects of the drug, including on cerebral perfusion and platelets. Specific scenarios are also important, including when to lower BP before, during, and after intravenous thrombolysis and endovascular therapy/thrombectomy, when it may be necessary to raise BP, and when antihypertensive drugs taken before stroke should be restarted. This narrative review addresses these and other questions. Although further large trials are ongoing, it is increasingly likely that there is no simple answer. Different subgroups of patients may need to have their BP lowered (eg, before or after thrombolysis), left alone, or elevated. © 2022 Lippincott Williams and Wilkins. All rights reserved.
Έτος δημοσίευσης:
2022
Συγγραφείς:
Bath, P.M.
Song, L.
Silva, G.S.
Mistry, E.
Petersen, N.
Tsivgoulis, G.
Mazighi, M.
Bang, O.Y.
Sandset, E.C.
Περιοδικό:
ISRN Stroke
Εκδότης:
Lippincott Williams and Wilkins
Τόμος:
53
Αριθμός / τεύχος:
4
Σελίδες:
1074-1084
Λέξεις-κλειδιά:
angiotensin receptor antagonist; antihypertensive agent; beta adrenergic receptor blocking agent; calcium channel blocking agent; dipeptidyl carboxypeptidase inhibitor; diuretic agent; fibrinolytic agent; glyceryl trinitrate; nitric oxide; antihypertensive agent, antihypertensive therapy; blood pressure; clinical trial (topic); endovascular surgery; fibrinolytic therapy; hospital; human; hypertension; ischemic stroke; nonhuman; pathophysiology; perioperative period; postoperative period; practice guideline; preoperative period; reperfusion; Review; stroke patient; brain ischemia; cerebrovascular accident; hypertension; physiology; treatment outcome, Antihypertensive Agents; Blood Pressure; Brain Ischemia; Humans; Hypertension; Ischemic Stroke; Stroke; Treatment Outcome
Επίσημο URL (Εκδότης):
DOI:
10.1161/STROKEAHA.121.036143
Το ψηφιακό υλικό του τεκμηρίου δεν είναι διαθέσιμο.